Gemcitabine plus platinum-based chemotherapy in combination with bevacizumab for kidney metastatic collecting duct and medullary carcinomas: Results of a prospective phase II trial (BEVABEL-GETUG/AFU24)
European Journal of Cancer · 2023-06 · 186 · 83-90
DOI: 10.1016/j.ejca.2023.03.018 ↗Kurz gefasst
Klinische Studie (Phase II) in der Zeitschrift European Journal of Cancer, 2023-06. Verfasst von Constance Thibault und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Hôpital Européen Georges Pompidou, Institut du Cancer Paris CARPEM, APHP-Centre, Université Paris Cité, Paris, France…. Hauptthemen laut MEDLINE: Carcinoma, Medullary, Carcinoma, Renal Cell, Kidney Neoplasms, Hypertension. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: Roche, Unicancer.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Oncology, Hôpital Européen Georges Pompidou, Institut du Cancer Paris CARPEM, APHP-Centre, Université Paris Cité, Paris, France; Université Paris Cité, AP-HP, Centre de Recherche des Cordeliers INS…
- Department of Medical Oncology, Centre Léon Bérard, Lyon, France.
- Department of Medical Oncology, Gustave Roussy, Université Paris-Saclay, Gustave Roussy, Villejuif, France.
- Department of Medical Oncology, Hôpital Henri Mondor, Créteil, France.
- Department of Medical Oncology, Institut de Cancérologie Strasbourg Europe, Strasbourg, France.
- Department of Medical Oncology, Centre hospitalo-Universitaire, Bordeaux, France.
Förderung
- Roche
- Unicancer
Zitieren
APA
Thibault, C., Fléchon, A., Albiges, L., Joly, C., Barthelemy, P., Gross-Goupil, M., Chevreau, C., Coquan, E., Rolland, F., Laguerre, B., Gravis, G., Pécuchet, N., Elaidi, R. T., Timsit, M. O., Brihoum, M., Auclin, E., de Reyniès, A., Allory, Y., & Oudard, S. (2023). Gemcitabine plus platinum-based chemotherapy in combination with bevacizumab for kidney metastatic collecting duct and medullary carcinomas: Results of a prospective phase II trial (BEVABEL-GETUG/AFU24). European Journal of Cancer, 186, 83-90. https://doi.org/10.1016/j.ejca.2023.03.018
Vancouver
Thibault C, Fléchon A, Albiges L, Joly C, Barthelemy P, Gross-Goupil M, et al. Gemcitabine plus platinum-based chemotherapy in combination with bevacizumab for kidney metastatic collecting duct and medullary carcinomas: Results of a prospective phase II trial (BEVABEL-GETUG/AFU24). European Journal of Cancer. 2023;186:83-90. doi:10.1016/j.ejca.2023.03.018
BibTeX
@article{Thibault2023,
author = {Thibault, Constance and Fléchon, Aude and Albiges, Laurence and Joly, Charlotte and Barthelemy, Philippe and Gross-Goupil, Marine and Chevreau, Christine and Coquan, Elodie and Rolland, Frédéric and Laguerre, Brigitte and Gravis, Gwenaelle and Pécuchet, Nicolas and Elaidi, Réza-Thierry and Timsit, Marc-Olivier and Brihoum, Meryem and Auclin, Edouard and de Reyniès, Aurélien and Allory, Yves and Oudard, Stéphane},
title = {Gemcitabine plus platinum-based chemotherapy in combination with bevacizumab for kidney metastatic collecting duct and medullary carcinomas: Results of a prospective phase II trial (BEVABEL-GETUG/AFU24)},
journal = {European Journal of Cancer},
year = {2023},
volume = {186},
pages = {83--90},
doi = {10.1016/j.ejca.2023.03.018}
}
EUVIMED